High response rates seen in phase-III trial of chemotherapy, new drug and stem cells in myeloma

Sunday, October 17, 2010 - 21:41 in Health & Medicine

The first study of its kind comparing two different approaches to treating newly diagnosed multiple myeloma has found that both treatments achieved a positive response, researchers say.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net